Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?What are alcohol's effects on ozempic?Is januvia still on the market?Mobic injection patent oehringer ingelheim france?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses, raising infection risks including from live vaccines. Guidelines recommend avoiding live vaccines like nasal spray flu shots (FluMist) while on Cosentyx and for weeks after stopping.[1][2]
Use inactivated or recombinant flu vaccines (standard needle shots like Fluzone, Fluarix, or Flublok), not live ones. These are safe during treatment per Novartis prescribing info and CDC advice for immunocompromised patients.[1][3]
Get vaccinated 4+ weeks before first Cosentyx dose to ensure immune response develops fully. Postponing shots until after vaccination avoids dampening antibody production.[1][2]
Annual flu shots can be given anytime during therapy with inactivated vaccines. No washout period needed, but efficacy may be lower due to immunosuppression—booster doses aren't routinely advised but discuss with doctor.[3][4]
Wait 4 weeks post-last dose before live vaccines; inactivated ones anytime. Drug clears in about 4-5 weeks (half-life ~27 days).[1]
Other Questions About Cosentyx :